NNNatascha C. Nüssler

Natascha C. Nüssler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Natascha C. Nüssler has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Peter Neuhaus

    6 shared publications
  • Andrea R. Müller

    From the *Department of Surgery, Charité, Campus Virchow-Klinikum, Humboldt University Berlin, Germany; †Department of Medicine I, University Ulm, Germany; and the ‡Department of Medical Immunology, Humboldt University Berlin, Germany

    2 shared publications
  • Andreas K. Nussler

    From the *Department of Surgery, Charité, Campus Virchow-Klinikum, Humboldt University Berlin, Germany; †Department of Medicine I, University Ulm, Germany; and the ‡Department of Medical Immunology, Humboldt University Berlin, Germany

    2 shared publications
  • B. Stange

    Department of Surgery, Charité, Campus Virchow-Klinikum, Humboldt Universität zu Berlin, Augustenburger Platz 1, D-13353 Berlin, GermanyTel.: +49-30-45052423 Fax: +49-30-45052900

    2 shared publications
  • Barbara Stange

    Department of Surgery, Charité Campus Virchow‐Klinikum, Humboldt University Berlin, Germany

    2 shared publications
  • P. Neuhaus

    Department of Surgery, Charité, Campus Virchow-Klinikum, Humboldt Universität zu Berlin, Augustenburger Platz 1, D-13353 Berlin, GermanyTel.: +49-30-45052423 Fax: +49-30-45052900

    2 shared publications

Latest Publications

  • Re: Effect of Enteral Nutrition and Symbiotics on Bacterial Infection Rates After Pylorus-Preserving Pancreatoduodenectomy

    by Nada Rayes, Daniel Seehofer, Tom Theruvath, Martina Mogl, Jan M. Langrehr, Natascha C. Nüssler, Peter Neuhaus, Stig Bengmark

  • Top Cited Papers
    Open Access

    Long-Term Survival and Predictors of Relapse After Orthotopic Liver Transplantation for Alcoholic Liver Disease

    by Robert Pfitzmann, Jeannette Schwenzer, Nada Rayes, Daniel Seehofer, Ruth Neuhaus, Natascha C. Nüssler

    The relevance of sobriety for outcome after orthotopic liver transplantation (OLT) for alcoholic liver disease (ALD) is still discussed controversially. We conducted a retrospective analysis of 300 patients transplanted for ALD with regard to recurrent alcohol consumption, risk factors for drinking after OLT, and long-term survival. The 300 patients underwent OLT for ALD between 1989 and 2002. Median follow-up was 89 months. Incidence and severity of drinking, survival rates, and causes of death were assessed. Age, gender, duration of pretransplant sobriety, social support, presence of children, and the results of psychosomatic evaluation were analyzed for their impact on recurrent alcohol consumption after OLT. Drinking of various degrees was observed in 19% of ALD patients after OLT. Pretransplant sobriety of less than 6 months, absence of companion in life, presence of young children, and a predicted poor psychosomatic prognosis were associated with an increased risk of recurrent alcohol consumption, whereas age and gender were not independent risk factors. Survival rates of patients who resumed abusive drinking were significantly lower than survival rates of abstinent patients or patients with minor lapses. Recurrent alcoholic liver disease accounted for the vast majority of deaths among patients who resumed abusive drinking after OLT, whereas malignant tumors, infections, and cardiovascular disease were the most common causes of death among abstinent patients. In conclusion, abusive drinking after OLT is associated with poor long-term survival. Analysis of risk factors may help to identify patients with a high risk for recurrent alcohol abuse after OLT. Liver Transpl, 2006. © 2006 AASLD.


    • 1 January 2004
      • p. 3-11

    Induction, expression and maintenance of cytochrome P450 isoforms in long-term cultures of primary human hepatocytes.

    by Jing Yuan, Liegang Liu, Masashi Shimada, Aiguo Wang, Maren Ruhnke, Peter Heeckt, Andrea R Muller, Natascha C Nussler, Peter Neuhaus, Andreas Nussler

    Within the past decade, tremendous progress has been made in the isolation and culture of human hepatocytes for drug metabolism and toxicology, which could potentially reduce the number of animal experiments performed. However, human hepatocyte cultures are still not widely used for preclinical drug testing, partly due to inconsistent supply and quality of human tissue. Thus, the aim of this study was to evaluate primary cultured human hepatocytes from different patients over a study period of 14 days, by assays that characterise cell quality and function. We found urea production and albumin synthesis in all cell cultures over at least 7 days. Cytochrome P4501A2, CYP2D6, and CYP3A4 protein expression was demonstrated by Western Blot analysis and CYP1A1/2 and CYP3A4 induction by 3-methylcholantrene, phenobarbital or rifampicin over 14 days. In addition, we saw that UDP-glucoronyltransferase activity was preserved in human hepatocytes over 2 weeks. In conclusion, we could show that primary human hepatocytes isolated from discarded liver tissue can consistently be kept in culture over a long time period and are therefore well suited for preclinical drug testing.


  • IL-10 Increases Tissue Injury After Selective Intestinal Ischemia/Reperfusion

    by Natascha C. Nüssler, Andrea R. Müller, Hans Weidenbach, Athanasios Vergopoulos, Klaus P. Platz, Hans-Dieter Volk, Peter Neuhaus, Andreas K. Nussler

    This study focused on the effect of immunoregulatory cytokines on tissue injury after intestinal ischemia/reperfusion (IR). Furthermore, the role of nitric oxide, heme oxygenase-1 (HO-1) and the transcription factor NF−κB/Rel in the disease process was evaluated. Oxidative stress and inflammatory gene products contribute to ischemia/reperfusion injury (IRI). However, expression of stress proteins such as the inducible nitric oxide synthase (NOS-2) and HO-1 might also provide protection against IRI. IR was achieved in Lewis rats by selective clamping of the superior mesenteric artery. IL-2 or IL-10 was administered intravenously before reperfusion. Animals were killed 1 hour, 4 hours, and 24 hours after reperfusion. Tissue destruction was assessed by hyaluronic acid (HA) and aminoaspartate-transaminase (AST) serum levels, whereas reduction of glutathione (GSH) tissue levels was used as a marker for oxidative stress. Furthermore, the activation of NF−κB/Rel and the expression of NOS-2 and HO-1 were analyzed. IR resulted in tissue destruction and significantly reduced GSH tissue levels in the intestines and liver. In addition, NF-κB/Rel activation and increased NOS-2 and HO-1 mRNA expression were detected in both organs after IR. IL-2 administration resulted in clinical improvement of the animals and was associated with increased NF-κB/Rel activation and enhanced NOS-2 and HO-1 mRNA expression. In contrast, IL-10 resulted in increased tissue destruction in both organs and sustained reduction of GSH levels in the intestines. Furthermore, IL-10 administration failed to enhance NF-κB/Rel activity, NOS-2 mRNA, or HO-1 mRNA expression after IR. IL-10 resulted in increased tissue damage after intestinal IR. This detrimental effect of IL-10 might have been the result of reduced NOS-2 and HO-1 mRNA expression. In contrast, the beneficial effect of IL-2 might have relied on increased HO-1 expression and NOS-2 activity. These controversial effects of IL-2 and IL-10 might have been mediated through transcriptional regulation of NOS-2 and HO-1 gene expression.


  • Diagnosis and treatment of arterial steal syndromes in liver transplant recipients

    by Natascha C. Nüssler, Utz Settmacher, Roland Haase, Barbara Stange, Michael Heise, Peter Neuhaus

    Arterial steal syndromes (ASSs) after orthotopic liver transplantation (OLT) are characterized by arterial hypoperfusion of the graft caused by shifting of blood flow into the splenic or gastroduodenal artery. Despite their potentially devastating consequences, such as ischemic biliary tract destruction or graft failure, ASSs have received little attention to date. We report the incidence, diagnosis, and treatment of ASS among 1,250 consecutive OLTs. ASS was observed in 69 patients (5.9%). All these patients presented with elevated liver enzyme levels, impaired graft function, or cholestasis. Treatment consisted of splenectomy (n = 18), coil embolization of the splenic or gastroduodenal artery (n = 29), or reduction in splenic artery blood flow through administration of an artificial stenosis (banding; n = 9). Mild symptoms of ASS did not warrant treatment in 13 patients. However, 3 of these patients developed ischemic biliary destruction requiring re-OLT. Serious complications also were observed after splenectomy and coil embolization, requiring re-OLT in 18%. Conversely, no complications were observed after banding the splenic artery. Prophylactic banding of the splenic artery was performed in 97 patients and was associated with a complication rate of 4%. In summary, the incidence of ASS is similar to that of other vascular complications. Untreated ASSs may lead to serious complications in more than 30% of patients. Of a variety of treatment options, banding the splenic artery was associated with the lowest complication rate. Banding also may be performed prophylactically in selected patients to prevent the development of ASS after OLT


  • NF-kappa B vermittelte NOS-2 Expression wirkt protektiv bei isolierter Dünndarmischämie

    by Natascha C. Nüssler, Andrea R. Müller, Peter Neuhaus, Andreas K. Nüssler

  • UPREGULATION OF INTRAEPITHELIAL LYMPHOCYTE (IEL) FUNCTION IN THE SMALL INTESTINAL MUCOSA IN SEPSIS

    by Natascha C. Nüssler, Barbara Stange, Andreas K. Nussler, Utz Settmacher, Jan M. Langrehr, Peter Neuhaus, Rosemary A. Hoffman

    Host defense mechanisms preventing bacterial invasion are particularly important in the gastrointestinal tract, since most gram-negative infections originate from there. Intraepithelial lymphocytes (IEL) seem to play an important role in this immune surveillance of the intestine, although their function in sepsis is not fully understood. To evaluate the characteristics of IEL in sepsis, C57BL/6 mice received a non-lethal dose of LPS and IEL were harvested at various time points thereafter. Although IEL displayed no phenotypic changes after endotoxemia, they displayed enhanced cytolytic activity and increased proliferation after LPS injection in addition, IEL from septic mice showed enhanced gamma interferon (IFN-γ) production after LPS administration. The production of IFN-γ may have induced the increased intestinal NOS-2 mRNA expression which was observed after endotoxemia. In conclusion, endotoxemia leads to functional activation of IEL without phenotypic changes. The activation of IEL and the subsequently increased NOS-2 expression may be important mechanisms in maintaining the mucosal barrier after sublethal LPS challenge.


  • Enhanced cytolytic activity of intestinal intraepithelial lymphocytes in patients with Crohn's disease

    by N. C. Nüssler, B. Stange, R. A. Hoffman, W. H. Schraut, A. J. Bauer, P. Neuhaus

    Background and aims: Dysfunction of the immune system with inappropriate responses of lymphocytes to various antigens has been implicated in the development of Crohn’s disease. Therefore, the functional and phenotypic characteristics of intestinal intraepithelial lymphocytes (IEL) in comparison to peripheral blood lymphocytes (PBL) were analyzed in patients with and without Crohn’s disease. Patients and methods: Six patients with Crohn’s disease and six control patients were studied. Isolated IEL and PBL were tested for cytolytic activity against the human adenocarcinoma cells DLD-1 and the human leukemia cells K562 in a 51Cr-release assay. Two-color flow cytometry was performed for phenotype analysis of isolated lymphocytes. Results: IEL from patients with Crohn’s disease showed significantly increased cytolytic activity against epithelial-derived target cells when compared with IEL from control patients. In contrast, no functional changes were detectable among PBL from patients with Crohn’s disease. IEL from patients with Crohn’s disease contained a significantly higher percentage of CD8+ lymphocytes when compared with IEL from control patients, whereas no phenotypic changes were observed among PBL. Conclusions: In Crohn’s disease, the functional and phenotypic changes of T cells are limited to lymphocytes of the intestinal mucosa. Furthermore, it is conceivable that the increased cytolytic activity of IEL contributes to the tissue damage in this disease.


  • Phenotypic and functional characteristics of intestinal intraepithelial lymphocytes during acute rejection of small intestinal allografts

    by Luca Cicalese, Natascha C. Nüssler, Rosemary A. Hoffman, Peter Neuhaus, Wolfgang H. Schraut

    Infiltration of a transplanted organ by host lymphoid cells is the hallmark of acute rejection. However, after intestinal transplantation, physiological lymphocyte migration may lead to host cell infiltration of the graft even in the absence of rejection. It is unclear whether this lymphocyte migration also involves the intraepithelial compartment of the graft or whether infiltration there is indicative of acute rejection. We demonstrate here that host cell infiltration of the intestinal mucosa occurs both during acute rejection of a small bowel allograft and, to a lesser extent, when rejection is prevented by immunosuppression with FK506. The infiltrating host cells consisted of CD3+ T cells with a predominant CD4-CD8+ phenotype resembling intraepithelial lymphocytes (IELs). Functional studies showed that the nonspecific cytolytic activity of IELs was not affected by acute rejection or by immunosuppression with FK506. These findings indicate that host cell infiltration of the intestinal mucosa does not connote an ongoing acute rejection. Furthermore, the decreased mucosal barrier function during acute rejection of intestinal allgrafts is probably not due to impaired cytolytic activity of IELs.